A comparison of risperidone and haloperidol for the risk of ischemic stroke in the elderly: a propensity score-matched cohort analysis

Abstract

Objective:

With an increase in antipsychotic use in the elderly, the safety profile of antipsychotics has been emphasized. Strong concerns have been raised about whether the risk of ischemic stroke differs between risperidone and haloperidol. This study compared the risk of ischemic stroke between elderly patients taking risperidone and haloperidol.

Method:

We conducted a retrospective cohort study using the Korea Health Insurance Review and Assessment Service database, applying a propensity-matched analysis. The cohort consisted of elderly patients who were newly prescribed haloperidol or risperidone between January 1, 2006 and December 31, 2009. Patients with prior cerebrovascular diseases (ICD-10, I60–I69), transient ischemic attack (ICD-10, G45), or cerebral tumors (ICD-10, C31) during 365 days prior to the initiation date were excluded. The study subjects were selected by propensity score matching. The outcome was defined as the first hospitalization for ischemic stroke (ICD-10, I63). Cox regression models were used to estimate the hazard ratio (HR) and 95% confidence intervals (95% CI) for ischemic stroke with haloperidol compared with risperidone use.

Results:

A total of 14,103 patients were included in the propensity-matched cohort for each drug. Overall, the incidence rate was higher for haloperidol users compared to the risperidone users (6.43 per 1000 person-years vs. 2.88 per 1000 person-years). A substantially increased risk was observed in haloperidol users (adjusted HR = 2.02, 95% CI, 1.12–3.62).

Conclusions:

The evidence showed that haloperidol should be prescribed in the elderly with caution.

Keywords

Risperidone haloperidol stroke brain ischemia aged geriatrics

Get full access to this article

View all access options for this article.

References

Abidi

Bhaskara

(2003) From chlorpromazine to clozapine – antipsychotic adverse effects and the clinician’s dilemma. Can J Psychiatry 48: 749–755.

Alexopoulos

Streim

Carpenter

. (2004) Using antipsychotic agents in older patients. J Clin Psychiatry 65: 5–104.

Austin

Mamdani

(2006) A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use. Stat Med 25: 2084–2106.

Barnes

(2011) Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 25: 567–620.

Blackstone

(2002) Comparing apples and oranges. J Thoracic Cardiovasc Surg 123: 8–15.

Clinical Research Center for Stroke (2013) Clinical Practice Guidelines for Stroke. Korea: Clinical Research Center for Stroke.

Currier

Trenton

(2002) Pharmacological treatment of psychotic agitation. CNS Drugs 16: 219–228.

Donnan

Fisher

Macleod

. (2008) Stroke. Lancet 371: 1612–1623.

Douglas

Smeeth

(2008) Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ 337: a1227.

10.

Finkel

Kozma

Long

. (2005) Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics. Int Psychogeriatr 17: 617–629.

11.

Gill

Rochon

Herrmann

. (2005) Atypical antipsychotic drugs and risk of ischaemic stroke: population-based retrospective cohort study. BMJ 330: 445.

12.

Goldstein

Bushnell

Adams

. (2011) Guidelines for the primary prevention of stroke. Stroke 42: 517–584.

13.

Herrmann

Mamdani

Lanctôt

(2004) Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 161: 1113–1115.

14.

Huybrechts

Schneeweiss

Gerhard

. (2012) Comparative safety of antipsychotic medications in nursing home residents. J Am Geriatr Soc 60: 420–429.

15.

European Registers of Stroke (EROS) Investigators (2009) Incidence of stroke in Europe at the beginning of the 21st century. Stroke 40: 1557–1563.

16.

Jung

Choi

Kim

. (2011) Short-acting nifedipine and risk of stroke in elderly hypertensive patients. Neurology 77: 1229–1234.

17.

Kales

Zivin

Kim

. (2011) Trends in antipsychotic use in dementia 1999–2007. Arch Gen Psychiatry 68: 190–197.

18.

Kleijer

Van Marum

Egberts

. (2009) Risk of cerebrovascular events in elderly users of antipsychotics. J Psychopharmacol 23: 909–914.

19.

Kuehn

(2005) FDA warns antipsychotic drugs may be risky for elderly. JAMA 293: 2462.

20.

Kwon

(2003) Payment system reform for health care providers in Korea. Health Policy Plan 18: 84–92.

21.

Laredo

Vargas

Blasco

. (2011) Risk of cerebrovascular accident associated with use of antipsychotics: population-based case-control study. J Am Geriatr Soc 59: 1182–1187.

22.

Liu

M-E

Tsai

S-J

Chang

W-C

. (2013) Population-based 5-year follow-up study in Taiwan of dementia and risk of stroke. PLoS One 8: e61771.

23.

Mazzucco

Cipriani

Barbui

. (2008) Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review. Mini Rev Med Chem 8: 776–783.

24.

Medicines and Healthcare Products Regulatory Agency (2004) New Advice Issued on Risperidone and Olanzapine. London: Medicines and Healthcare Products Regulatory Agency.

25.

Mehndiratta

Khan

Mehndiratta

. (2014) Stroke in Asia: geographical variations and temporal trends. J Neurol Neurosurg Psychiatry: jnnp-2013–306992.

26.

Mehta

Johnson

Chen

. (2010) Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study. J Clin Psychiatry 71: 689–698.

27.

Parsons

(2001) Reducing bias in a propensity score matched-pair sample using greedy matching techniques. In: Proceedings of the 26th annual SAS users group international conference, Long Beach, CA, 22–25 April 2001. Cary, NC: SAS Institute Inc.

28.

Percudani

Barbui

Fortino

. (2005) Second-generation antipsychotics and risk of cerebrovascular accidents in the elderly. J Clin Psychopharmacol 25: 468–470.

29.

Quan

Sundararajan

Halfon

. (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43: 1130–1139.

30.

Rosenbaum

Rubin

(1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70: 41–55.

31.

Sacchetti

Turrina

Cesana

. (2010a) Timing of stroke in elderly people exposed to typical and atypical antipsychotics: a replication cohort study after the paper of Kleijer et al. J Psychopharmacol 24: 1131–1132.

32.

Sacchetti

Turrina

Valsecchi

(2010b) Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review. Drug Saf 33: 273–288.

33.

Shin

J-Y

Choi

N-K

Jung

S-Y

. (2011) Overlapping medication associated with healthcare switching among Korean elderly diabetic patients. J Korean Med Sci 26: 1461–1468.

34.

Vasilyeva

Biscontri

Enns

. (2013) Adverse events in elderly users of antipsychotic pharmacotherapy in the Province of Manitoba: a retrospective cohort study. J Clin Psychopharmacol 33: 24–30.

35.

Wallaschofski

Donne

Eigenthaler

. (2001) Prl as a novel potent cofactor for platelet aggregation. J Clin Endocrinol Metab 86: 5912–5919.

36.

Wang

Schneeweiss

Setoguchi

. (2007) Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications. J Clin Psychopharmacol 27: 707–710.

37.

Wooltorton

(2002) Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. CMAJ 167: 1269–1270.